Thromboelastometry (<scp>ROTEM</scp>) Assessing Hypercoagulability in Patients Referred for Thrombophilia Screening
ROTEM does not appear to be a strong discriminatory test. However, it can detect hypercoagulopathy in patients referred for thrombophilia screening. Abnormal ROTEM may indicate a higher risk for recurrence. However, this can only be determined in prospective cohort studies.
Authors
- Michael Nagler (ORCID: https://orcid.org/0000-0003-4319-2367)
- Maha Othman (ORCID: https://orcid.org/0000-0001-7562-203X)
- Mona Ali Mahmoud Assar (ORCID: https://orcid.org/0000-0001-7632-6064)
- Wilma M. Hopman
- Henning Nilius (ORCID: https://orcid.org/0000-0002-1323-3116)
- Natalie Kearn (ORCID: https://orcid.org/0000-0002-2544-1684)
Institutions
- University of Bern (CH)
- University of British Columbia (CA)
- Mansoura University (EG)
- Queen's University (CA)
- University Hospital of Bern (CH)
- Kingston Health Sciences Centre (CA)
- St. Lawrence College (CA)
Publication Details
- Journal
- International Journal of Laboratory Hematology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1111/ijlh.14443
- Citations
- 2
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.74
Funders
- Abbott Laboratories
- Sysmex Corporation
- Siemens Healthineers
- Roche Diagnostics